Mickey Duos
Adult Health · Alexandria, LANPI 1922291327
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 197 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AbbVie at 27.5% of the total.
Across 197 payments — averaging $16.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$890
- GSK$381
- Astellas Pharma US Inc$220
- Axsome Therapeutics, Inc.$185
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$148
- Dexcom, Inc.$145
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,13997%
- Education$943%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 60 | $890 |
| GSK | 25 | $381 |
| Astellas Pharma US Inc | 9 | $220 |
| Axsome Therapeutics, Inc. | 9 | $185 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $148 |
| Dexcom, Inc. | 8 | $145 |
| Ardelyx, Inc. | 8 | $145 |
| Novo Nordisk | 9 | $141 |
| Endo Pharmaceuticals Inc. | 11 | $120 |
| Antares Pharma, Inc. | 6 | $107 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $78 |
| Lilly USA, LLC | 5 | $77 |
| Pfizer | 5 | $76 |
| AstraZeneca | 4 | $75 |
| Exact Sciences | 4 | $66 |
| Novartis | 3 | $44 |
| Tolmar Pharmaceuticals, Inc. | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Dendreon Pharmaceuticals LLC | 1 | $34 |
| Johnson & Johnson | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Alfasigma USA, Inc. | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Coloplast | 1 | $17 |
| Vifor Pharma, Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
| Myovant Sciences Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Amgen | 1 | $13 |
| Acerus Pharmaceuticals Corporation | 1 | $12 |
| Myriad Genetic Laboratories, Inc. | 1 | $12 |
How this compares
$3,233 in reported general payments places this provider in the 70th percentile of 203 adult health providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 80 | $82,011 |
| RybelsusSemaglutide | 33 | $38,818 |
| MounjaroTirzepatide | 34 | $36,951 |
| TrulicityDulaglutide | 32 | $31,721 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $25,384 |
| LinzessLinaclotide | 34 | $25,328 |
| JanuviaSitagliptin Phosphate | 11 | $10,000 |
| FarxigaDapagliflozin Propanediol | 12 | $9,860 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $3,495 |
| Gabapentin | 124 | $1,985 |
| Omeprazole | 141 | $1,674 |
| Amlodipine Besylate | 213 | $1,443 |
| Fluticasone Propionate | 123 | $1,378 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 67 | $1,376 |
| Atorvastatin Calcium | 195 | $1,329 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $141 | $120,829113 claims |
| Lilly USA, LLCMounjaro, Trulicity | $77 | $68,67366 claims |
| GSKTrelegy Ellipta | $381 | $25,38434 claims |
| AbbVieLinzess | $890 | $25,32834 claims |
| AstraZenecaFarxiga, Symbicort | $75 | $13,35527 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 203 adult health providers in Louisiana.
Other adult health in Alexandria
- Catherine PinckleyAlexandria$4K
- Joan SmithBaton Rouge$121K
- Fiona WinterbottomNew Orleans$51K
- Damika HarmonLake Charles$27K
- Jade CarrereHouma$23K
- Deborah SmithBaton Rouge$18K
- Tanisha SmithBaton Rouge$17K
- Eva Marina StaffordBaton Rouge$15K
- Dustin DenicolaBaton Rouge$14K
- Melissa LamaPonchatoula$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.